Advertisement
Advertisement
U.S. Markets close in 6 mins
Advertisement
Advertisement
Advertisement
Advertisement

Izotropic Corporation (1R3.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
0.5270-0.0500 (-8.67%)
As of 08:11PM CET. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.5770
Open0.5470
Bid0.5240 x N/A
Ask0.5550 x N/A
Day's Range0.5270 - 0.5470
52 Week Range0.2200 - 0.6920
Volume11,400
Avg. Volume1,439
Market Cap22.707M
Beta (5Y Monthly)2.69
PE Ratio (TTM)N/A
EPS (TTM)-0.0840
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing

    Vancouver, British Columbia--(Newsfile Corp. - December 1, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers is pleased to announce that it has completed the final engineering of IzoView.IzoView is now fully assembled and being prepared for final software testing and certifi

  • Newsfile

    Alexander Tokman Joins Izotropic Board of Directors

    Vancouver, British Columbia--(Newsfile Corp. - November 11, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, announces that Advisor Mr. Alexander Tokman has joined the Company's Board of Directors. Strengthening the Board of Directors with strategic and well-connected indu

  • Newsfile

    Izotropic's IzoView Is Weeks Away from Final Engineering & Showcasing to Investment and Scientific Communities

    Vancouver, British Columbia--(Newsfile Corp. - October 25, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT (computed tomography) imaging platform, for the more accurate detection and diagnosis of breast cancers, announces that the engineering and construction of IzoView is weeks away from completion and subsequent unveiling to existing shareholders, and the investment, medic

Advertisement
Advertisement